Open Access

Mineralcorticoid-antagonists in chronic kidney disease and Type 2 Diabetes: Key clinical findings from current studies.

Congress Session

About the speaker

Professor Roland Schmieder

University Hospital Erlangen, Department of Nephrology and Hypertension, Erlangen (Germany)
25 presentations
0 follower

3 more presentations in this session

Welcome and introduction.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Finerenone in reducing mortality and morbidity in diabetic kidney disease

Speaker: Professor G. Filippatos (Athens, GR)

Thumbnail

Discussion and closure.

Thumbnail

Access the full session

Improving cardiovascular and renal outcomes in diabetic kidney disease

Speakers: Professor R. Schmieder, Professor S. Anker, Professor G. Filippatos
Thumbnail

About the event

Image

Heart Failure 2021 Online Congress

29 June - 1 July 2021

Sessions Presentations

Related content

Open Access

Rethinking coronary artery disease: diagnosis and treatment.

27 August 2021

Open Access

Replacing the pill: the future of CVD therapy.

27 August 2021

Open Access

The ECG and beyond: artificial intelligence will penetrate cardiology practice.

27 August 2021

This platform is supported by

logo Novo Nordisk